Oncology

J.M. Nigro, S.J. Baker, A.C. Preisinger, J.M. Jessup, et al., "Mutations in the p53 gene occur in diverse human tumour types," Nature, 342, 705-8, 7 December 1989. Janice M. Nigro (Johns Hopkins Oncology Center, Baltimore): "`Cancer' represents a broad spectrum of diseases. Although all cancers involve abnormal cellular proliferation, the cell type involved and the biologic behavior of the cancerous tissues vary widely. For many years, investigators have been searching for abnormalities that a

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

J.M. Nigro, S.J. Baker, A.C. Preisinger, J.M. Jessup, et al., "Mutations in the p53 gene occur in diverse human tumour types," Nature, 342, 705-8, 7 December 1989.

Janice M. Nigro (Johns Hopkins Oncology Center, Baltimore): "`Cancer' represents a broad spectrum of diseases. Although all cancers involve abnormal cellular proliferation, the cell type involved and the biologic behavior of the cancerous tissues vary widely. For many years, investigators have been searching for abnormalities that are shared by several cancers in the hope that such changes would illuminate fundamental, general aspects of neoplasia. The cited paper suggests that p53 gene mutations may be such an abnormality. The gene was discovered through association with viral oncogene products and was subsequently shown to be altered by point mutation in two colorectal tumors. The new paper showed that p53 was subtly mutated in a variety of human cancers, including those of the breast, brain, lung, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies